BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33062427)

  • 1. Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma.
    Ji B; Chen L; Cai Q; Guo Q; Chen Z; He D
    PeerJ; 2020; 8():e9943. PubMed ID: 33062427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Defined Necroptosis-Related miRNAs Signature for Predicting the Prognosis of Colon Cancer.
    Yang Z; Lu S; Wang Y; Tang H; Wang B; Sun X; Qu J; Rao B
    Int J Gen Med; 2022; 15():555-565. PubMed ID: 35046713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
    Yang G; Zhang Y; Yang J
    Front Oncol; 2019; 9():1207. PubMed ID: 31799184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a novel microRNA-based signature for predicting the prognosis of glioma.
    Liu G; Rong X; Lin X; Wang H; He L; Peng Y
    Int J Neurosci; 2023 Dec; 133(8):840-850. PubMed ID: 35353669
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a 7-miRNA signature for predicting the prognosis of patients with lung adenocarcinoma.
    Liu R; Guo Z; Huang J; Li J; Tan Q; Luo Q
    Exp Biol Med (Maywood); 2022 Apr; 247(8):641-657. PubMed ID: 35068222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic analysis and
    Li W; Kong X; Huang T; Shen L; Wu P; Chen QF
    Ann Transl Med; 2020 Nov; 8(21):1422. PubMed ID: 33313167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma.
    Li X; Shi Y; Yin Z; Xue X; Zhou B
    J Transl Med; 2014 Jun; 12():159. PubMed ID: 24893932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.
    Jacob H; Stanisavljevic L; Storli KE; Hestetun KE; Dahl O; Myklebust MP
    Oncotarget; 2017 Oct; 8(50):87837-87847. PubMed ID: 29152124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel M7G-Related MicroRNAs Risk Signature Predicts the Prognosis and Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma.
    Hong P; Du H; Tong M; Cao Q; Hu D; Ma J; Jin Y; Li Z; Huang W; Tong G
    Front Genet; 2022; 13():922358. PubMed ID: 35812727
    [No Abstract]   [Full Text] [Related]  

  • 11. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
    Gene; 2019 May; 697():86-93. PubMed ID: 30779946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative Analysis Identified a 6-miRNA Prognostic Signature in Nasopharyngeal Carcinoma.
    Chen Y; Wang Z; Li H; Li Y
    Front Cell Dev Biol; 2021; 9():661105. PubMed ID: 34336826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma.
    Meng T; Wang Q; Yang Y; Ren Y; Shi Y
    Front Genet; 2022; 13():825261. PubMed ID: 35495130
    [No Abstract]   [Full Text] [Related]  

  • 14. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma.
    Xiao K; Liu Q; Peng G; Su J; Qin CY; Wang XY
    PeerJ; 2020; 8():e8312. PubMed ID: 31921517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Illustrating the biological functions and diagnostic value of transmembrane protein family members in glioma.
    Zhang Y; Zhang W; Yuan Q; Hong W; Yin P; Shen T; Fang L; Jiang J; Shi F; Chen W
    Front Oncol; 2023; 13():1145676. PubMed ID: 37064154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.
    Xiao H; Bai J; Yan M; Ji K; Tian W; Liu D; Ning T; Liu X; Zou J
    World Neurosurg; 2019 Jun; 126():e765-e772. PubMed ID: 30853516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.